Ontario’s COVID-19 Genomics Rapid Response Coalition 



To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.



Standardized Sequencing Methodologies



Data Management & Sharing

The ON-CoV Coalition is designed to provide for method standardization and coordination of:


Collecting Patient Samples and Metadata




Data Curation and Management


Epidemiological Studies 

This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.

Why Genomics?

Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19

pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19. 

The results reported by the Coalition will inform vaccine and therapeutic development.

Why Ontario Genomics?

Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms. 

Ontario Genomics is well-positioned to provide and promote:


ONCoV Genomics Coalition Members

Aaron Campigotto

University of Toronto

Bettina Hamelin

Ontario Genomics

Samira Mubareka

Sunnybrook Health Sciences / University of Toronto

Danielle Brabant-Kirwan

Health Sciences North

Robyn Lee

Dalla Lana School of Public Health, University of Toronto

Letitia Nadalin Penno

Canadore College

Nahuel Fittipaldi

Public Health Ontario

Andrew G. McArthur

McMaster University

Marc Fiume


Allison McGeer

Sinai Health Systems

Stephen Scherer

Hospital for Sick Children / University of Toronto


Prameet M. Sheth

Kingston Health Sciences Centre / Queen’s University

Jared Simpson

Ontario Institute for Cancer Research

Michael Szego

Unity Health Toronto / University of Toronto

David Villeneuve

Canadore College

Bo Wang

Peter Munk Cardiac Centre, UHN / University of Toronto


Sarah Wootton

University of Guelph


We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.






“The COVID Cloud Platform is an incredible platform that brings together resources & capacity to enable timely & comprehensive genomic analysis of #SARSCoV2 for our province & our country,” said Bettina Hamelin @ONGenomicsCEO , whose team leads the #ONCoV Genomics Coalition.

Request for Proposals:

Canadian SARS-CoV-2 Genomics Data Portal

Genome Canada has requested for proposals to develop a Canadian SARS-CoV-2 Genomics Data Portal to enhance the value of sequence data. Application submission deadline: March 3rd, 2021

Ontario lab pioneering new COVID-19 test method calls for all positive samples to be checked for variants

This technology developed at LTRI, Mount Sinai Health was not originally intended for COVID-19, but senior investigator Jeff Wrana realized the platform they were using could be pivoted to detect variants with speed and accuracy.

February 26, 2021

February 3, 2021

Ontario to tap into genomics database

February 4, 2021

© 2020 by Ontario Genomics